SCM
HRMY icon

Sterling Capital Management’s Harmony Biosciences HRMY Stock Holding History

Sterling Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Sell
5,739
-3,152
-35% -$103K ﹤0.01% 1259
2025
Q4 		$333K Buy
8,891
+715
+9% +$23.5K 0.01% 1142
2025
Q3 		$225K Hold
8,176
– – ﹤0.01% 1288
2025
Q2 		$258K Buy
8,176
+67
+0.8% +$2.15K ﹤0.01% 1204
2025
Q1 		$269K Sell
8,109
-850
-9% -$30.5K ﹤0.01% 1130
2024
Q4 		$308K Buy
8,959
+9
+0.1% +$309 ﹤0.01% 1157
2024
Q3 		$358K Buy
+8,950
New +$314K ﹤0.01% 1053

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sterling Capital Management's HRMY Position: Q1 2026 in Review

Sterling Capital Management reduced its Harmony Biosciences (HRMY) stake by 35% in Q1 2026, selling an estimated $103K and leaving 5,739 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Sterling Capital Management first reported a position in HRMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $358K in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Sterling Capital Management held 5,739 shares of Harmony Biosciences worth $161K as of Q1 2026.
  • Sterling Capital Management sold 3,152 Harmony Biosciences shares in Q1 2026, an estimated $103K.
  • Harmony Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1259 holding.
  • Sterling Capital Management first reported a position in Harmony Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Harmony Biosciences position peaked at $358K in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.